Preciphos

Team & Governance

A demanding technology
led by an experienced team.

Preciphos brings together scientific, medical, technical, financial and business profiles capable of taking a medtech platform from research through to industrialization, commercialization and international expansion.

Discover FoRe Technology
Get in Touch with Preciphos
5
Complementary leadership areas of expertise
4
Co-founders within the team
4
Experts serving on the Advisory Board
From Scientific Research to MedTech Development

From scientific research
to medtech development.

Developing a platform like FoRe requires a rare combination of expertise: scientific knowledge, medical vision, technical excellence, industrial capabilities, financial leadership, and business development. The Preciphos team brings these competencies together around a shared ambition—to transform a research-driven innovation into a portable immunological analysis platform.

SCIENTIFIC
R&D Expertise
Drive the scientific and technological evolution of the platform.
MEDICAL
Medical Development
Guide applications, scientific priorities, and validation activities.
TECHNICAL
Technical Excellence
Prepare for industrialization, reliability, and scalability.
FINANCE
Financial Leadership
Structure financial strategy, projections, and investor engagement.
BUSINESS
Business Vision
Drive development, partnerships, and long-term growth.
A Complementary Leadership Team

Expertise brought together
around a shared objective.

Preciphos’s governance is built on an experienced leadership team that combines the essential competencies required to structure the development of FoRe: R&D, technology, medical development, finance, and corporate strategy.

EXECUTIVE LEADERSHIP
Michel Paolucci
Chief Executive Officer

Michel Paolucci brings extensive experience in business development and strategic leadership. His role is to support the company’s structuring, growth trajectory, and positioning with partners, investors, and target markets.

40 years
of experience in business development
Request an Investor Discussion
DEVELOPMENT & R&D
Dr Bernard Ludwig
Chief Development Officer, Co-Founder

Leads the scientific and strategic development of the FoRe platform, its applications, and its potential deployment across medical, scientific, and international markets.

43 years
of R&D experience
TECHNOLOGY
Pascal Pflimlin
Chief Technical Officer, Co-Founder

Leads the technical dimension of Preciphos, including FoRe’s core technology, platform reliability, ongoing development, and preparation for future industrialization stages.

45 years
of R&D experience
MEDICAL DEVELOPMENT
Dr Nathalie Satta Poschung
Chief Medical Development Officer

Provides critical medical and scientific expertise, guiding medical priorities, potential applications, validation requirements, and engagement with healthcare and research environments.

29 years
of experience in medical research
FINANCE & CORPORATE STRUCTURING
Nicolas Ludwig
Chief Financial Officer, Co-Founder

Oversees financial structuring, economic planning, forecasting, and investor relations, supporting the preparation of the company’s next financing milestones.

20 years
of experience in finance and controlling
Advisory Board

An advisory board to strengthen strategy,
networks and expertise.

Preciphos is also supported by an advisory board bringing together complementary expertise across medical, strategic, financial, institutional, and international fields.

SD
Simone Di Tonnob
CEO, Institut Choiseul
STRATEGY & INSTITUTIONAL AFFAIRS
JG
Dr Joris Galland
Deputy Medical Director, Digital Medical Hub
MEDICAL
HV
Huber Veltz
Former Executive Board Member, Banque Transatlantique
FINANCE
RB
Rolland Boehler
Africa Strategy & Business Development
INTERNATIONAL
Governance & Complementarity

Structured governance
to support the next steps.

Preciphos’s progress is driven by a clear alignment between strategic vision, scientific development, technical expertise, medical oversight, financial leadership, and the support of external advisors. This complementary structure is essential for advancing clinical validation, industrialization, regulatory certifications, commercial deployment, and international expansion.

01
Structure Validation Activities
Guide the next stages of medical and scientific validation.
02
Prepare for Industrialization

Support reliability, manufacturing readiness, and production scale-up.

03
Support Fundraising Efforts
Present a clear and credible growth trajectory to qualified investors.
04
Develop Target Markets
Identify priority business units, strategic partners, and key geographic markets.
Explore the Investor Roadmap
A Team Serving a MedTech Ambition

Transforming a scientific innovation
into a deployable platform.

Preciphos is pursuing a clear ambition: to transform a research-driven technology into a deployable medtech platform capable of progressively addressing multiple application environments, starting with medical, hospital, and scientific priorities.

Scientific rigor and medical understanding at the core of decision-making.
Business strategy and financial structuring designed to support future scale-up.
International development driven by an experienced leadership team.
Explore the Business Units
Discover the Investor Opportunity
LET'S TALK

Would you like to speak
with the Preciphos team?

Preciphos offers qualified discussions with investors, hospital leaders, researchers, institutional stakeholders, and industrial partners who would like to gain a deeper understanding of the FoRe technology, its applications, and its development roadmap.

Contact Preciphos
Access the Investor Area